ArticleUrology case reports2025
Locally advanced primary urethral carcinoma in an HIV-positive female patient: report of a case successfully managed with definitive concurrent chemoradiotherapy at a referral cancer center in Abidjan.
Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Female Primary urethral carcinoma is a rare malignancy frequently diagnosed at an advanced stage. Surgery, the most common treatment modality, is associated with substantial functional impairment. Here, we present the case of a 45-year-old HIV-positive woman with locally advanced squamous cell carcinoma infiltrating the bladder, vagina, and left obturator muscle, treated with definitive concurrent chemoradiotherapy combining fractionated external beam radiotherapy and weekly cisplatin. The treatment resulted in complete remission, which was sustained after 25 months of follow-up. This case supports the effectiveness of definitive concurrent chemoradiotherapy as an organ-preserving approach for advanced female squamous cell carcinoma of urethra.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.